Rafael Fonseca, MD: MRD testing has gained significant prominence as a diagnostic test at this meeting and previous ones. Obviously ,this refers to the determination of minimal residual disease status ...
Prospective detection of chemoradiation resistance in patients with locally advanced esophageal adenocarcinoma. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract does ...
EZH2Now Testing Program is first of its kind to offer national single gene testing for EZH2 EZH2 is an epigenetic regulator of B-cell identity and plays a role in both normal B-cell biology and the ...
Dublin, Oct. 23, 2024 (GLOBE NEWSWIRE) -- The "Global Checkpoint Inhibitor Refractory Cancer Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Application, End-User, Inhibitor ...
Multiple myeloma is considered to be relapsed if symptoms of the disease appear after a time of improvement. It’s considered to be refractory when it gets worse even though it’s being treated. To ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, today launched the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results